Correction to Supporting Information for Jensen et al., Bcl2L13 is a ceramide synthase inhibitor in glioblastoma. . Proc Natl Acad Sci U S A 2025;122:e2507673122.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to Supporting Information for Jensen et al., Bcl2L13 is a ceramide synthase inhibitor in glioblastoma. Proc Natl Acad Sci U S A 2025;122:e2507673122.
PMID: 40344001